KANGJI MEDICAL clarifies: TPG maintains its equity stake in the company unchanged
KANGJI MEDICAL issued a statement clarifying that TPG's equity stake remains unchanged, in response to recent reports about TPG shareholders selling their shares. The company emphasized that TPG's equity stake has not been affected, and pointed out that the disclosure notice of the interests of two TPG individuals was submitted in accordance with Hong Kong regulations and should not be interpreted separately
According to the news report recently noted by KANGJI MEDICAL (09997) on the Zhitong Finance APP, the company has issued an announcement stating that two individuals from the company's major shareholder TPG are reportedly selling all of the company's shareholding interests.
In order to avoid any confusion that may arise among the company's shareholders and potential investors, the company hereby clarifies that as of the date of this announcement, TPG's shareholding interests in the company remain unchanged. The company further inquired with TPG and was informed that the latest equity disclosure notices from the two individuals from TPG were submitted in accordance with Part XV of the Securities and Futures Ordinance Chapter 571 of the laws of Hong Kong, and should not be considered separately in relation to TPG's shareholding interests in the company
